Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-167.15M
↓ 79% below average
Average (6y)
$-93.49M
Historical baseline
Range
High:$-14.54M
Low:$-190.34M
CAGR
+50.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-167.15M | +12.2% |
| 2023 | $-190.34M | -44.1% |
| 2022 | $-132.04M | -94.5% |
| 2021 | $-67.90M | -12.7% |
| 2020 | $-60.27M | -171.5% |
| 2019 | $-22.20M | -52.7% |
| 2018 | $-14.54M | - |